Lepu Medical
Lepu Medical
Engaged in the R&D, production and sales of cardiovascular disease plant intervention diagnosis and treatment equipment and cardiovascular drugs.
Lepu Medical, founded in June, 1999 and headquartered in Beijing, is an enterprise engaged in the R&D, production and sales of cardiovascular drugs and cardiovascular disease plant interventional diagnosis and treatment equipment . The founder is Pu Zhongjie. Listed on the SZSE on October 30, 2009, the company's major shareholders are Luoyang Ship Material Research Institute, Pu Zhongjie and WP Medical Technologies, INC. Rivals that have direct and indirect competition with Lepu Medical include Peijia, Kintor, Aprea Therapeutics, Viela, etc.
- All
- News
- Analysis
- Research
Briefing Sep 30, 2021 02:41 PM
· Healthcare
AstraZeneca acquires Caelum Biosciences overweight rare diseases business
Briefing Sep 27, 2021 11:57 AM
· Healthcare
Triarm therapeutics completed a round of financing of US $60 million
In depth
Briefing Sep 13, 2021 09:21 AM
· Healthcare
Xushui Internet obtained tens of millions of yuan pre-A round of financing to accelerate the research and development of medical equipment aiot and digital applications
Apr 22, 2021 03:11 PM
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:39 AM
Aug 09, 2020 12:23 AM
Briefing Aug 31, 2021 05:29 PM
· Healthcare
Dashi pharmaceutical completed a round of financing of nearly 100 million yuan
Briefing Aug 18, 2021 09:37 AM
· Healthcare
Yiying medical obtained 65 million yuan of a + round financing to accelerate the expansion of intraoperative 3D imaging equipment product line
Briefing Jul 31, 2021 06:23 PM
· Healthcare
GE Healthcare and Tsinghua Industrial Research Institute landed on the health science and technology innovation platform G ² Chuang · Center
Briefing Jul 20, 2021 07:03 PM
· Healthcare
State Affairs Office: revise and issue the negative list of market access (2021 version) before the end of the year to carry out the pilot of relaxing market access
Insight
Healthcare
Sinopharm COVID Vaccine Receives WHO Emergency Use Certification
The Sinopharm Group’s COVID Vaccine is the sixth vaccine to receive safety, efficacy and quality verification from the World Health Organization (WHO). It is the first vaccine from a non-Western country to receive WHO certification.
May 11, 2021 03:35 AM
Briefing Jul 14, 2021 09:22 AM
· Healthcare
Juyi technology completed more than RMB 100 million round B financing to accelerate the development of medical device cdmo business
Briefing Jul 07, 2021 11:55 AM
· Healthcare
Saite smart gets exclusive round a financing from CITIC Securities
Briefing Jul 06, 2021 09:02 AM
· Healthcare
Shende medical has obtained financing of over 100 million yuan in round B and round B +, and focused ultrasound precision noninvasive treatment accelerates product layout
Briefing Jul 02, 2021 02:10 PM
· Healthcare
Li Jidian: the production capacity of next year has been fully reserved, and it can be listed before the end of the year
Briefing May 27, 2021 02:02 AM
· Healthcare
Alibaba Health Information publishes rather poor annual figures
Briefing Feb 01, 2021 02:41 PM
· Healthcare
Bh009 new drug project independently researched and developed by Beihai biological Co., Ltd. was approved by China's clinical trials
See more
Related Companies
EqualOcean Analysis
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.